company background image
PHAR

Egyptian International Pharmaceutical Industries CASE:PHAR Stock Report

Last Price

ج.م32.12

Market Cap

ج.م3.2b

7D

-3.7%

1Y

-15.5%

Updated

27 Nov, 2022

Data

Company Financials +
PHAR fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance4/6
Financial Health4/6
Dividends2/6

PHAR Stock Overview

Egyptian International Pharmaceutical Industries Company produces and sells pharmaceuticals primarily in Egypt.

Egyptian International Pharmaceutical Industries Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Egyptian International Pharmaceutical Industries
Historical stock prices
Current Share Priceج.م32.12
52 Week Highج.م43.50
52 Week Lowج.م27.80
Beta0.12
1 Month Change6.64%
3 Month Change4.83%
1 Year Change-15.50%
3 Year Change-54.10%
5 Year Change-66.82%
Change since IPO474.42%

Recent News & Updates

Recent updates

Shareholder Returns

PHAREG PharmaceuticalsEG Market
7D-3.7%-4.3%2.3%
1Y-15.5%6.5%9.9%

Return vs Industry: PHAR underperformed the EG Pharmaceuticals industry which returned 6.5% over the past year.

Return vs Market: PHAR underperformed the EG Market which returned 9.9% over the past year.

Price Volatility

Is PHAR's price volatile compared to industry and market?
PHAR volatility
PHAR Average Weekly Movement3.5%
Pharmaceuticals Industry Average Movement4.3%
Market Average Movement5.6%
10% most volatile stocks in EG Market8.9%
10% least volatile stocks in EG Market3.4%

Stable Share Price: PHAR is less volatile than 75% of EG stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: PHAR's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1980n/aAhmed Kelanihttps://www.eipico.com.eg

Egyptian International Pharmaceutical Industries Company produces and sells pharmaceuticals primarily in Egypt. It produces various dosage forms, such as the spansule capsules, soft gelatin capsules, lyophilized products, gels, sprayers, and effervescent tablets. The company’s products include anaesthetics, antibiotics, antifungals, antihistaminic products, antiparasitic products, antiviral products, blood-forming drugs, cardiovascular drugs, dental products, dermatology products, gastrointestinal drugs, genitourinary system drugs, hospital products, musculoskeletal drugs, nervous system drugs, ophthalmic products, oral antidiabetic products, otorhinolaryngology drugs, psychiatry drugs, pulmonics, systemic corticosteroids, systemic hormones, vitamins, electrolytes and combinations, and other products, as well as analgesics, antipyretics, and anticatarrhal drugs.

Egyptian International Pharmaceutical Industries Company Fundamentals Summary

How do Egyptian International Pharmaceutical Industries's earnings and revenue compare to its market cap?
PHAR fundamental statistics
Market Capج.م3.19b
Earnings (TTM)ج.م590.47m
Revenue (TTM)ج.م3.62b

5.4x

P/E Ratio

0.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PHAR income statement (TTM)
Revenueج.م3.62b
Cost of Revenueج.م2.01b
Gross Profitج.م1.61b
Other Expensesج.م1.02b
Earningsج.م590.47m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)5.95
Gross Margin44.56%
Net Profit Margin16.30%
Debt/Equity Ratio79.3%

How did PHAR perform over the long term?

See historical performance and comparison

Dividends

4.7%

Current Dividend Yield

25%

Payout Ratio